推薦產(chǎn)品
2-hydroxy-2-(pyrrolidin-2-yl)aceticacid 5-hydroxy-3,3-dimethyldihydrofuran-2(3H)-one methyl3-oxo-4-m-tolylbutanoate ethyl3-oxo-4-o-tolylbutanoate methyl2,4-dioxopentanoate 1H-pyrazolo[3,4-b]pyridine-3-carboxylicacid 5-(2,2,2-trifluoroethoxy)picolinicacid 2,3-dihydroxyterephthalicacid 4-(tert-butoxycarbonyl)morpholine-2-carboxylicacid 2-(4-fluorobenzyloxy)aceticacid 2-(2-fluorocyclohexyloxy)aceticacid 2-(tetrahydro-2H-pyran-4-yloxy)aceticacid 2-(pyridin-4-ylmethoxy)aceticacid 2-(cyclopentyloxy)aceticacid 2-(pyrazin-2-ylmethoxy)aceticacid 2-((4-(trifluoromethyl)pyridin-3-yl)methoxy)aceticacid 2-(pyridazin-3-yloxy)aceticacid 2-(pyridin-2-ylamino)aceticacid 2-(1H-pyrrolo[3,2-b]pyridin-3-yl)aceticacid 2-(1H-pyrrolo[2,3-c]pyridin-3-yl)aceticacid 2-(2-methyl-1H-imidazol-1-yl)aceticacid 2-(1H-indol-3-yl)propanoicacid 2-(1H-indol-1-yl)aceticacid 2-(1H-1,2,3-triazol-1-yl)aceticacid 2-(1H-benzo[d][1,2,3]triazol-1-yl)aceticacid ethyl2-bromo-2-phenylacetate ethyl2-bromo-2-(2-bromophenyl)acetate 1-(tert-butoxycarbonyl)azetidine-3-carboxylicacid 1-(benzyloxycarbonyl)pyrrolidine-3-carboxylicacid 1-tert-butyl3-methylazetidine-1,3-dicarboxylate 2-methylpyrido[2,3-b]pyrazin-3(4H)-one isothiazol-4-aminehydrochloride tert-butyl2-oxa-7-azaspiro[3.5]nonane-7-carboxylate 2-oxa-7-azaspiro[3.5]nonane 4-hydrazinylpyridin-2(1H)-one (7H-pyrrolo[2,3-d]pyrimidin-4-yl)methanaminehydrochloride 1-cyclopropylpiperazine 7-oxa-2-azaspiro[3.5]nonanehydrochloride 4,4-difluorocyclohexanaminehydrochloride 4-(1,3,4-oxadiazol-2-yl)aniline 4-(1,2,4-oxadiazol-3-yl)aniline 3,4-dihydro-2H-benzo[b][1,4]oxazine 3-(1-methyl-1H-pyrazol-4-yl)aniline piperazin-2-one methylpyrrolidine-3-carboxylate 2-(8-fluoronaphthalen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 6-(dimethylamino)-4-methylpyridin-3-ylboronicacid 3-bromo-7-chloro-5-methyl-1H-pyrazolo[4,3-b]pyridine 7-chloro-5-methyl-1H-pyrazolo[4,3-b]pyridine 5-bromo-3,3-dimethylindolin-2-one 市場(chǎng)行情 近日硫酸鉀的價(jià)格幾乎是全盤(pán)上漲，尤其是羅鉀近兩周連續(xù)兩次調(diào)漲百元，使得部分曼海姆廠家也又試探性地往上多喊了一點(diǎn)。然而就此說(shuō)硫酸鉀市場(chǎng)大有轉(zhuǎn)弱為強(qiáng)的趨勢(shì)，似乎也有點(diǎn)不夠準(zhǔn)確。筆者認(rèn)為硫酸鉀行情應(yīng)只是有所好轉(zhuǎn)。首先水鹽體系貨源緊張，但整體硫酸鉀供應(yīng)并不緊張，所以水鹽硫酸鉀漲價(jià)只是減少了整體硫酸鉀低價(jià)的風(fēng)險(xiǎn)；其次，曼海姆行業(yè)開(kāi)工率長(zhǎng)期居高不下，雖然現(xiàn)在沒(méi)有庫(kù)存，但是需求本身并無(wú)亮點(diǎn)，再加上明春新產(chǎn)能威脅，所以供需總體看是較為平衡的，并不趨緊；第三，氯化鉀價(jià)格已經(jīng)趨近頂點(diǎn)，副產(chǎn)品鹽酸行情整體看好于往年，硫酸鉀成本壓力也并不絕對(duì)。所以硫酸鉀的市場(chǎng)行情雖在好轉(zhuǎn)，卻不一定能再現(xiàn)今年二季度的輝煌。
氯化鉀冷也不冷，硫酸鉀熱也不熱，對(duì)于這倆肥種暫時(shí)都建議下游以按需采購(gòu)為主即可；至于賣方，氯化鉀是新大合同重中重，硫酸鉀是手里有單再任性。
